Tetherex Pharmaceuticals

Developing novel therapeutics for inflammatory, infectious diseases, and cancer

placeOklahoma City, Oklahoma, United States calendar_todayFounded 2014 groups8 employees language tetherex.com

Registered entities

Innovation

7 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 197 times.

YearFilings
20141
20181
20244
20253
20261

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon